UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 402

Sortiert nach

Amyloid‐ß‐directed immunotherapy for Alzheimer's disease

Journal of internal medicine, 2014-03, Vol.275 (3), p.284-295

2014

Link zum Volltext

Verfügbarkeit prüfen

Impaired insulin secretion increases the risk of Alzheimer disease

Neurology, 2008-09, Vol.71 (14), p.1065

2008

Link zum Volltext

Verfügbarkeit prüfen

S.25.04 Immunotherapy in Alzheimer's disease – targeting toxic Aβ protofibrils

European neuropsychopharmacology, 2012-10, Vol.22, p.S143-S143

Lannfelt, L

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study

European journal of clinical nutrition, 2012-08, Vol.66 (8), p.885-890

2012

Link zum Volltext

Verfügbarkeit prüfen

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

Annals of clinical biochemistry, 2009-05, Vol.46 (Pt 3), p.235

2009

Link zum Volltext

Verfügbarkeit prüfen

Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men

Diabetologia, 2009-08, Vol.52 (8), p.1504-1510

2009

Link zum Volltext

Verfügbarkeit prüfen

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils

Aging brain, 2023-01, Vol.4, p.100086-100086, Article 100086

2023

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease

BMC geriatrics, 2017-09, Vol.17 (1), p.208-208, Article 208

2017

Link zum Volltext

Verfügbarkeit prüfen

High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer's disease

Dementia and geriatric cognitive disorders, 2014-01, Vol.37 (3-4), p.196

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease

Dementia and geriatric cognitive disorders, 2007-01, Vol.24 (4), p.247

2007

Link zum Volltext

Verfügbarkeit prüfen

The Amyloid-β Pathway in Alzheimer's Disease

Molecular psychiatry, 2021-10, Vol.26 (10), p.5481-5503

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum cystatin C and the risk of Alzheimer disease in elderly men

Neurology, 2008-09, Vol.71 (14), p.1072

2008

Link zum Volltext

Verfügbarkeit prüfen

Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Nature medicine, 1996-08, Vol.2 (8), p.864-870

1996

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-beta-directed immunotherapy for Alzheimer's disease

Journal of internal medicine, 2014-03, Vol.275 (3), p.284

2014

Link zum Volltext

Verfügbarkeit prüfen

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus

Leukemia, 2015-10, Vol.29 (10), p.2069-2074

2015

Link zum Volltext

Verfügbarkeit prüfen

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

The Journal of clinical investigation, 1997-12, Vol.100 (12), p.3005-3013

1997

Link zum Volltext

Verfügbarkeit prüfen

9th Key symposium Introduction: Updating Alzheimer's disease diagnosis implications for prevention and treatment

Journal of internal medicine, 2014-03, Vol.275 (3), p.202-203

2014

Link zum Volltext

Verfügbarkeit prüfen

Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice

Neuroscience, 2009-10, Vol.163 (2), p.540-551

2009

Link zum Volltext

Verfügbarkeit prüfen

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

Journal of Alzheimer's disease, 2012-01, Vol.32 (2), p.273

2012

Link zum Volltext

Verfügbarkeit prüfen

Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers

Journal of molecular biology, 2004-05, Vol.339 (1), p.145-159

2004

Link zum Volltext

Verfügbarkeit prüfen

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

Diabetologia, 2008-03, Vol.51 (3), p.464-472

2008

Link zum Volltext

Verfügbarkeit prüfen

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Dementia and geriatric cognitive disorders, 2010-01, Vol.29 (3), p.204

2010

Link zum Volltext

Verfügbarkeit prüfen

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

Nature (London), 1995-08, Vol.376 (6543), p.775-778

1995

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants near the MGAT1 gene are associated with body weight, BMI and fatty acid metabolism among adults and children

International Journal of Obesity, 2012-01, Vol.36 (1), p.119-129

2012

Link zum Volltext

Verfügbarkeit prüfen

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Acta neurologica Scandinavica, 2010-10, Vol.122 (4), p.270-277

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 402

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(240)
Science & Technology
(220)
Life Sciences & Biomedicine
(211)
Medicin Och Hälsovetenskap
(195)
Male
(133)
Aged
(130)
Female
(127)
Neurosciences & Neurology
(126)
Biological And Medical Sciences
(125)
Alzheimer's Disease
(120)
Alzheimer Disease - Genetics
(119)
Medical Sciences
(117)
Middle Aged
(116)
Neurology
(115)
Neurosciences
(87)
Aged, 80 And Over
(68)
Mutation
(62)
Clinical Neurology
(58)
Adult
(52)
Amyloid Beta-Protein Precursor - Genetics
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Amyloid‐ß‐directed immunotherapy for Alzheimer's disease

Impaired insulin secretion increases the risk of Alzheimer disease

S.25.04 Immunotherapy in Alzheimer's disease – targeting toxic Aβ protofibrils

Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils

Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease

High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer's disease

Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease

The Amyloid-β Pathway in Alzheimer's Disease

Serum cystatin C and the risk of Alzheimer disease in elderly men

Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Amyloid-beta-directed immunotherapy for Alzheimer's disease

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

9th Key symposium Introduction: Updating Alzheimer's disease diagnosis implications for prevention and treatment

Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

Genetic variants near the MGAT1 gene are associated with body weight, BMI and fatty acid metabolism among adults and children

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Suchergebnisse filtern